When converting individuals from set ratio opioid/non-opioid drug regimens a choice should be designed whether or not to continue the non-opioid analgesic. If a call is produced to discontinue using non-opioid analgesic, it might be needed to titrate the dose of ROXICODONE in response to the extent of analgesia and adverse results afforded from the